DataClue.io

Pharmaceutical Research and Development for Discovering New Drug Opportunities

Health Tech & Life Sciences
Non Active, Nov 2021 ceased to operate

Company Overview

Snapshot

Founded in February 2019 by Osnat Ben Nesher Zaretsky, Maytal Bivas-Benita, and Tanya Yankelevich, DataClue.io operated with 1–10 employees. The company ceased operations in November 2021.

Business overview

DataClue.io was an early-stage digital health startup focused on pharmaceutical and biomedical drug research and development. The company aimed to assist large pharmaceutical companies in discovering new drug opportunities through data analysis, shortening time to market, and facilitating internal and external collaboration in clinical research and drug development. It intended to achieve these objectives by identifying new drug opportunities via clinical trial cross-analysis and managing collaboration rights, operating within the Health Tech & Life Sciences sector, specifically Digital Healthcare and Medical Decision Support, and utilizing Artificial Intelligence, Machine Learning, Natural Language Processing, and Blockchain technologies.

Company Intelligence Q&A

What was DataClue.io's primary focus?
DataClue.io focused on pharmaceutical and biomedical drug research and development, aiming to help pharmaceutical companies discover new drug opportunities and shorten time to market.
When was DataClue.io founded?
DataClue.io was founded in February 2019.
Who were the co-founders of DataClue.io?
The co-founders of DataClue.io were Osnat Ben Nesher Zaretsky, Maytal Bivas-Benita, and Tanya Yankelevich.
What technologies did DataClue.io utilize?
DataClue.io utilized technologies such as Artificial Intelligence, Machine Learning, Natural Language Processing, and Blockchain.
What was the operational status of DataClue.io?
DataClue.io ceased to operate in November 2021.

External links